Medicine and Dentistry
25 Hydroxyvitamin D
6%
Colecalciferol
100%
Disease Activity
6%
Drug Megadose
100%
Expanded Disability Status Scale
6%
Glatiramer
31%
Hazard Ratio
6%
Hypercalcaemia
6%
Kidney Stone
6%
Low Drug Dose
43%
Migraine
6%
Multiple Sclerosis
100%
Neurology
6%
Proportional Hazards Model
6%
Randomized Clinical Trial
100%
Supplementation
100%
Topiramate
6%
Ureter Stone
6%
Vitamin D
31%
Keyphrases
Black Participants
6%
Clinical Relapse
12%
Concomitant Treatment
6%
Copaxone
6%
Cox Proportional Hazards Model
6%
Disease Activity
6%
Expanded Disability Status Scale
6%
Glatiramer Acetate
25%
Hazard Ratio
6%
High Dose
100%
Hypercalcemia
6%
International Units
18%
Kaplan-Meier
6%
Migraine
6%
Multiple Sclerosis
12%
Multiple Sclerosis Relapse
6%
Nephrolithiasis
6%
Neurology Clinic
6%
Neuroscience
6%
Randomized Clinical Trial
100%
Relapsing-remitting MS
18%
Relapsing-remitting multiple Sclerosis
100%
Safety Analysis
6%
Serum 25-hydroxyvitamin D
6%
Topiramate
6%
United States
6%
Ureterolithiasis
6%
Vitamin D
25%
Vitamin D Deficiency
6%
Vitamin D3
100%
Pharmacology, Toxicology and Pharmaceutical Science
25 Hydroxyvitamin D
6%
Cholecalciferol
100%
Disease Activity
6%
Expanded Disability Status Scale
6%
Glatiramer
31%
Hypercalcaemia
6%
Migraine
6%
Multiple Sclerosis
100%
Nephrolithiasis
6%
Randomized Clinical Trial
100%
Topiramate
6%
Ureter Stone
6%
Vitamin D
31%